Trial site
Qingdao Central Hospital
- 12running trials
- 8closed trials
The trials here
What the 20 trials at this site are about, from their registry records.
- Conditions
- Lung cancer7 trials
- Fatty liver disease (MASLD/MASH)2 trials
- Metastatic breast cancer2 trials
- Migraine2 trials
- Ovarian cancer2 trials
- Stroke2 trials
- Brain metastases1 trial
- Chronic lymphocytic leukaemia1 trial
- Colorectal cancer1 trial
- Diffuse large B-cell lymphoma1 trial
- Endometrial cancer1 trial
- Follicular lymphoma1 trial
- and 2 more
- Phase
- Phase 39 trials
- Phase 25 trials
- Phase 1/22 trials
- Phase 2/32 trials
- Status
- Completed8 trials
- Active, not recruiting6 trials
- Recruiting6 trials
- Lead sponsor
- Pfizer3 trials
- Qingdao Central Hospital2 trials
- Beijing Tiantan Hospital1 trial
- BeOne Medicines1 trial
- Betta Pharmaceuticals Co., Ltd.1 trial
- and 12 more
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer3 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Colorectal cancer1 recruiting
- Follicular lymphoma1 recruiting
- Head and neck cancer1 recruiting
- Mantle cell lymphoma1 recruiting
- Metastatic breast cancer1 recruiting
- Stroke1 recruiting
Closed trials
Completed
Completed
Completed
A Study to Learn About Zavegepant as the Acute Treatment of Migraine in Asian Adults
Completed
A Study to Learn About the Safety and Effects of Rimegepant to Prevent Migraine in Chinese Subjects.
Completed
Completed
Completed
Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026